Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2016

Drugs and Therapeutics (D & T) Committee

Drugs Under Review for:

September 14, 2016

Drug Name Review Type Class Manufacturer
Viekira HR New Drug Initial Review Hepatitis C AbbVie
Ocaliva New Drug Initial Review Primary Biliary Cholangitis Intercept Pharmaceuticals
Briviact New Drug Initial Review Anticonvulsant UCB, Inc.
Epclusa New Drug Initial Review Hepatitis C Gilead Sciences
Xtampza ER New Drug Initial Review Extended Release Opioid Collegium Pharmaceutical
Spinosad New Drug Initial Review Lice Treatment ParaPro
Adzenys XR-ODT New Drug Initial Review Stimulant Neos Therapeutics
Orenitram New Drug Appeal Pulmonary Arterial Hypertension United Therapeutics